Cue biopharma to present at two upcoming investor healthcare conferences in november

Cambridge, mass., nov. 10, 2021 (globe newswire) -- cue biopharma, inc. (nasdaq: cue), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics designed to selectively engage and modulate targeted t cells directly within the patient's body, announced today that it will take part in two fireside chats, the first at the stifel healthcare conference 2021, november 15-17, and the second at the jefferies london healthcare conference, november 16-19. both conferences will be held virtually.
CUE Ratings Summary
CUE Quant Ranking